Friday, November 13, 2020
GREENWICH, Conn.--(BUSINESS WIRE)--
Join us as we discuss today’s pressing healthcare issues.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005535/en/

Bunny Ellerin, Director, HPM, Columbia Business School, MBA, Harvard Business School, BA, Columbia University (Photo: Business Wire)
CO-HOSTS:
| Bunny Ellerin | Jing He |
Director, HPM, Columbia Business School | Biotech Analyst, Gabelli Funds |
| - MBA, Harvard Business School
| - MBA, Columbia Business School
|
| - MA, Washington University in St. Louis
|
| |
Time | Agenda |
9:00 – 9:10 AM | Welcome |
- Bunny Ellerin, Director, Healthcare and Pharmaceutical Management Program
|
9:10 – 10:00 AM | Vaccines & Therapeutics to Treat COVID-19 |
- David Hering, Regional President, North America, Pfizer Vaccines
|
- Dr. Jacqueline Miller, Senior Vice President, Infectious Diseases, Moderna
|
- Dr. David Weinreich, Senior Vice President, Global Clinical Development, Regeneron
|
- (Moderator) Jing He ‘15, Biotech Analyst, Gabelli Funds
|
10:10 – 11:00 AM | Health Policy & Reimbursement Trends |
- Dr. Deepa Kumaraiah, Senior Vice President, Service Lines and Chief Physician, NYP Medical Groups, New York-Presbyterian
|
- Melissa Schulman, Senior Vice President of Government Affairs, CVS Health
|
- Professor Michael Sparer, Chair, Health Policy and Management, Columbia University Mailman School of Public Health
|
- (Moderator) Jeff Jonas, Portfolio Manager, Gabelli Funds
|
11:10 – Noon | Healthcare Delivery in a Virtual World |
- Dr. Amy Fahrenkopf, President, HSS Health and Senior Vice President, Hospital for Special Surgery
|
- Jason Gorevic, CEO, Teladoc Health
|
- Dr. Julie Silverstein, Divisional President, Oak Street Health
|
- (Moderator) Kevin Kedra, Healthcare Analyst, G.research
|
Click Here to Register
Gabelli Funds, LLC is a registered investment adviser with the Securities and Exchange Commission and is a wholly owned subsidiary of GAMCO Investors, Inc. (NYSE: GBL).

View source version on businesswire.com: https://www.businesswire.com/news/home/20201019005535/en/
Douglas R. Jamieson
914-921-5020
djamieson@gabelli.com
Source: Gabelli Funds, LLC